Registered title, quoted from ClinicalTrials.gov
Daoyin Technique for Improving Exercise Endurance in IPF
An open trial on idiopathic pulmonary fibrosis, registered on ClinicalTrials.gov. Led by Affiliated Hospital of Liaoning University of Traditional Chinese Medicine; 3 other hospitals on this site are listed as study sites.
Status, phase and start date as registered on ClinicalTrials.gov on 13 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.
The study team’s contact details are on the registry record. This site does not pass on enquiries.
Hospitals in mainland China listed for this trial 4
Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.
- Lead sponsorAffiliated Hospital of Liaoning University of Traditional Chinese Medicine辽宁中医药大学附属医院ShenyangHospital page
- Study siteAffiliated Hospital of Liaoning University of Traditional Chinese Medicinenese Medicine辽宁中医药大学附属医院ShenyangHospital page
- Study siteFirst Affiliated Hospital of Henan University of Traditional Chinese Medicine河南中医学院第一医院ZhengzhouHospital page
- Study siteXiyuan Hospital中国中医科学院西苑医院BeijingHospital page
The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov
Source: ClinicalTrials.gov record NCT07019714, read on 13 Nov 2026; hospital names matched to this site’s hospital list. How names are matched
Checklist for this trial 2
Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.
Show the checklist (2 points)Hide the checklist
40 years to 85 years; sex: all
Registered eligibility fields
Pregnant or lactating women, and patients with a recent pregnancy plan.
Exclusion criterion 8
Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.
Questions to ask the study team
Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07019714, read on 10 Nov 2026.
Registered criteria
Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.
Inclusion Criteria:
- Patients who meet the diagnostic criteria for IPF;
- Those who can tolerate guided - technique training;
- Aged between 40 and 85 years old;
- Those who can independently or with the assistance of family members use devices such as smartphones and computers during home - based training;
- Those who voluntarily accept treatment and sign the informed consent form.
Exclusion Criteria:
- Patients in the acute exacerbation phase of IPF.
- Patients with comorbidities such as chronic obstructive pulmonary disease, lung cancer, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism, and other pulmonary diseases.
- Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, cardiac function at grade 3 or above, stroke, cerebral hemorrhage, etc.).
- Patients with severe liver diseases (such as bleeding caused by liver cirrhosis, portal hypertension, and esophagogastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.).
- Patients with severe osteoarthropathy or osteoporosis, and those with unstable fractures.
- Patients with progressive neuromuscular diseases.
- Patients with unclear consciousness, dementia, and various mental illnesses.
- Pregnant or lactating women, and patients with a recent pregnancy plan.
- Patients who have been participating in other clinical trials within 1 month before enrollment.
- Patients who need long - term use of ventilators and those with unstable vital signs while bedridden.
Quoted from ClinicalTrials.gov, NCT07019714, participation criteria. Read on 10 Nov 2026.
Where this information comes from
The registry record
ClinicalTrials.gov (US National Library of Medicine), record NCT07019714, read on 13 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.
Diseases and hospitals
The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions
What is left out
Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.